1. Home
  2. WLGS vs SBFM Comparison

WLGS vs SBFM Comparison

Compare WLGS & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WLGS
  • SBFM
  • Stock Information
  • Founded
  • WLGS 1981
  • SBFM 2006
  • Country
  • WLGS Hong Kong
  • SBFM Canada
  • Employees
  • WLGS N/A
  • SBFM N/A
  • Industry
  • WLGS Engineering & Construction
  • SBFM Biotechnology: Pharmaceutical Preparations
  • Sector
  • WLGS Consumer Discretionary
  • SBFM Health Care
  • Exchange
  • WLGS Nasdaq
  • SBFM Nasdaq
  • Market Cap
  • WLGS 8.5M
  • SBFM 7.4M
  • IPO Year
  • WLGS 2023
  • SBFM N/A
  • Fundamental
  • Price
  • WLGS $0.56
  • SBFM $0.33
  • Analyst Decision
  • WLGS
  • SBFM Strong Buy
  • Analyst Count
  • WLGS 0
  • SBFM 1
  • Target Price
  • WLGS N/A
  • SBFM $260.00
  • AVG Volume (30 Days)
  • WLGS 125.5K
  • SBFM 3.3M
  • Earning Date
  • WLGS 08-02-2024
  • SBFM 08-08-2024
  • Dividend Yield
  • WLGS N/A
  • SBFM N/A
  • EPS Growth
  • WLGS N/A
  • SBFM N/A
  • EPS
  • WLGS N/A
  • SBFM N/A
  • Revenue
  • WLGS $6,825,879.00
  • SBFM $26,739,780.00
  • Revenue This Year
  • WLGS N/A
  • SBFM $87.97
  • Revenue Next Year
  • WLGS N/A
  • SBFM $125.23
  • P/E Ratio
  • WLGS N/A
  • SBFM N/A
  • Revenue Growth
  • WLGS 65.07
  • SBFM 193.30
  • 52 Week Low
  • WLGS $0.40
  • SBFM $0.28
  • 52 Week High
  • WLGS $1.46
  • SBFM $64.50
  • Technical
  • Relative Strength Index (RSI)
  • WLGS 46.70
  • SBFM 35.00
  • Support Level
  • WLGS $0.52
  • SBFM $0.29
  • Resistance Level
  • WLGS $0.60
  • SBFM $0.38
  • Average True Range (ATR)
  • WLGS 0.05
  • SBFM 0.05
  • MACD
  • WLGS -0.01
  • SBFM 0.05
  • Stochastic Oscillator
  • WLGS 13.33
  • SBFM 24.31

About WLGS Wang & Lee Group Inc.

WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED (WLHK). WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage (220v/phase 1 or 380v/phase 3) electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, and water supply and sewage disposal systems.

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.

Share on Social Networks: